ACCEL RESEARCH SITES NETWORK
DEAD

Serial Number

97915045

Owner

Clinical Research Holdings, LLC

Attorney

Mark A. Wright

First Use Date

Oct 31, 2022

Filing Date

May 1, 2023

Add to watchlist:

No watchlists yet
View on USPTO

ACCEL RESEARCH SITES NETWORK Trademark

Serial Number: 97915045

ACCEL RESEARCH SITES NETWORK is a trademark filed by Clinical Research Holdings, LLC on May 1, 2023. The trademark is classified under Class 42 (Computer & Scientific), Class 45 (Legal & Security Services), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

Clinical Research Holdings, LLC (5 trademarks)

615 Crescent Executive Court
Lake Mary, FL 32746

Entity Type: 16

Trademark Details

Filing Date

May 1, 2023

Registration Date

Not Registered

First Use Anywhere

October 31, 2022

First Use in Commerce

October 31, 2022

Goods & Services

Business consulting and management in the field of clinical trials in all phases as it relates to pre-study document collection and review, site selection, visits and audits, site compliance, project tracking and monitoring reports, negotiation and administration of investigator grants and clinical trial budgets and contracts, financial and management accounting, distribution, coordination and tracking of clinical trial products and materials, regulatory document processing, laboratory selection and coordination; Business consulting and management in the field of clinical trials in all phases as it relates to managing site and study-specific subject recruitment strategies and programs in the nature of contingency strategies and solutions to address specific project challenges; Business consulting and management in the field of clinical trials in all phases as it relates to managing the development of all study related documents and materials in the nature of study protocols, contracts, budgets, amendments, paper and electronic case report forms, informed consent forms, safety narratives, presentation posters, and training manuals; Business consulting and management in the field of clinical trials in all phases as it relates to managing all aspects of study, drug reconciliation, and inventory and distribution reports; Business management for all aspects of clinical trials in all phases as it relates to managing investigators, coordinators, monitors, technicians, and participants for compliance with clinical protocols and regulations; Business consulting and management in the field of clinical trials in all phases as it relates to management and compilation of computerized databases in the field of clinical trials for business purposes; Business consulting and management in the field of clinical trials in all phases as it relates to ethical reviews, namely, submitting clinical trial protocols to institutional review boards and independent ethics committees on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical trials; Statistical analysis and reporting services for business purposes in the field of clinical trials; Business project management in the field of clinical trials in all phases as it relates to organizing and conducting business meetings of clinical trial investigators; Business management, namely, managing randomization logistics, in the pharmaceutical and biotechnological field for business purposes; Development and implementation of personnel recruitment and retention programs for investigators, coordinators, monitors, technicians and participants for use in clinical trials; Business consulting and management in the field of clinical trials in all phases as it relates to the administration of protocols involving volunteer research patients and the recruiting of such volunteer research patients; Providing data management services in the medical, pharmaceutical and biotechnological field for business purposes

Regulatory affairs, namely, reviewing standards and practices to assure compliance with clinical trial laws and regulations; Providing independent review of clinical trials involving human subjects, namely, reviewing research protocols and related information to ensure protection of the rights and welfare of human subjects of research

Medical and scientific research consulting services for others in the field of design, planning, and implementation of clinical trials in all phases; providing quality assurance services in the pharmaceutical and biotechnological industries

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
May 13, 2024 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
May 13, 2024 ABN2
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 29, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 29, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 29, 2024 REAP
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 26, 2024 GNRN
NON-FINAL ACTION E-MAILED
Jan 26, 2024 GNRT
NON-FINAL ACTION WRITTEN
Jan 26, 2024 CNRT
ASSIGNED TO EXAMINER
Jan 26, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 30, 2023 NWOS
NEW APPLICATION ENTERED
May 4, 2023 NWAP